Improving life for people with Rare Bleeding Disorders
About us
Hemorare is a clinical and commercial-stage company, committed to developing and bringing to global market effective and accessible treatments for congenital bleeding disorders that remain largely underdiagnosed or undertreated today.
Our strength lies in our knowledge and deep expertise in rare disease and blood disorders, and a broad collaborative network of experts.
Our commitment is to understand and serve patient needs. Their resilience, their expectations, their real-life experience constantly inspire and nurture our work.
The team
Gioacchino De Giorgi
+30 years experience in Drugs for Rare disease Med Affair, Commercial, Business Developement, Corporate Strategy
C- suite & Boad position
Track record in Innovation,
Global Marketing Strategy, M&A
Claudio Rumazza
...
Under Construction
Aruna Koganti
20 years experience in Drug Development and Approval
Drug Development Strategies, Regulatory Affairs & Compliance Strategies
Orphan Drug Development
Over 50 FDA applications
Succesful Orphan drug designations
20 patents
Richard Hendrick
Education and communication to break silos
Under Construction
Alessandro Gringeri
A life in Blood and Rare Disorders across Academia and Industry
Int Medicine Professor at Milan Univeristy
Senior Consultant in Hematology
Industry Leadership in Med Affair
+180 peer reviewed publications
+ 400 lectures in conferences
+ 10 years as CMO / CSO